Login
Super Investors / MFS New Discovery Fund

MFS New Discovery Fund

Mfs Series Trust I · net assets $2.09B · 109 holdings as of February 28, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 99.0% · STIV: 1.0% · DE: 0.0%

Financial position

Total assets
$2.12B
Total liabilities
$22.1M
Net assets
$2.09B
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$0

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $13.5M $15.2M $18.7M
Reinvestment $0 $0 $0
Redemptions $52.6M $47.7M $31.9M
Net realized gain (non-derivative) $28.1M $6.28M $-12.1M
Net unrealized appreciation (non-derivative) $-47.8M $80.8M $16.9M

The three months of the reporting period, as filed; month 3 ends February 28, 2026.

Filing details

Registrant
Mfs Series Trust I
Registrant CIK
798244
Registrant LEI
549300QRB5FQ35HH3533
Series
MFS New Discovery Fund
Series ID
S000000765
Series LEI
ZVEMRLDGMDO1D1VDSU87
SEC file number
811-04777
Address
111 HUNTINGTON AVENUE, BOSTON, US-MA, 02199, US
Phone
617-954-5000
Form
NPORT-P
Filed
April 24, 2026
Report period ends
August 31, 2026
Report month ends
February 28, 2026
Accession number
000141036826040078
Holding Value % of net assets
Mfs Institutional Money Market Portfolio EC $103M 4.93%
Advanced Energy Industries Inc EC $60.8M 2.90%
Ligand Pharmaceuticals Inc EC $47.7M 2.28%
Qxo Inc EC $46.7M 2.23%
Modine Manufacturing Co EC $40.3M 1.93%
Nvent Electric PLC EC $39.2M 1.87%
Macom Technology Solutions Holdings Inc EC $38.8M 1.85%
Bio-techne Corp EC $38M 1.82%
Littelfuse Inc EC $34M 1.62%
Flowserve Corp EC $32.3M 1.54%
Nlight Inc EC $31.9M 1.52%
Chefs' Warehouse Inc/the EC $31.4M 1.50%
Legence Corp EC $31M 1.48%
Jfrog Ltd EC $30.9M 1.48%
Crane Co EC $30.9M 1.48%
Xpo Inc EC $30.8M 1.47%
Primoris Services Corp EC $30.8M 1.47%
Topbuild Corp EC $30.5M 1.45%
Integer Holdings Corp EC $28.9M 1.38%
Caci International Inc EC $28.5M 1.36%
Terreno Realty Corp EC $28.5M 1.36%
Formfactor Inc EC $28.4M 1.36%
Knife River Corp EC $28.4M 1.35%
Leonardo Drs Inc EC $28.2M 1.35%
Ttm Technologies Inc EC $27.6M 1.32%
Charles River Laboratories International Inc EC $27.1M 1.29%
Hamilton Lane Inc EC $26.9M 1.28%
Bloom Energy Corp EC $25.2M 1.20%
James Hardie Industries PLC EC $24.9M 1.19%
Ionis Pharmaceuticals Inc EC $24.9M 1.19%
Patrick Industries Inc EC $24.1M 1.15%
Waystar Holding Corp EC $23.8M 1.14%
Schrodinger Inc/united States EC $23.4M 1.12%
Element Solutions Inc EC $23.1M 1.10%
Technipfmc PLC EC $22.8M 1.09%
Ollie's Bargain Outlet Holdings Inc EC $22.7M 1.09%
Pjt Partners Inc EC $22.5M 1.07%
Collegium Pharmaceutical Inc EC $22.5M 1.07%
Simpson Manufacturing Co Inc EC $22.1M 1.06%
Brunswick Corp/de EC $22M 1.05%
Jp Morgan Us Government Money Market Fund STIV $21.4M 1.02%
Standardaero Inc EC $19.8M 0.95%
Ascendis Pharma A/s EC $19M 0.91%
Wisdomtree Inc EC $18.9M 0.90%
Globus Medical Inc EC $18.3M 0.87%
Alkami Technology Inc EC $18.2M 0.87%
Genius Sports Ltd EC $18M 0.86%
Birkenstock Holding PLC EC $17.8M 0.85%
Ccc Intelligent Solutions Holdings Inc EC $17.8M 0.85%
Amprius Technologies Inc EC $17.4M 0.83%
Dutch Bros Inc EC $17.2M 0.82%
Genedx Holdings Corp EC $17.1M 0.82%
Azenta Inc EC $17.1M 0.82%
Ufp Technologies Inc EC $17M 0.81%
Biolife Solutions Inc EC $17M 0.81%
Matador Resources Co EC $16.5M 0.79%
Antero Resources Corp EC $16.4M 0.79%
Viper Energy Inc EC $16.4M 0.78%
Guardant Health Inc EC $16.2M 0.77%
Box Inc EC $15.9M 0.76%

Showing top 60 of 109 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support